BCD, designs, manufactures, and markets medical devices. It reported earnings per share of $0.56 in...

70.2K

Verified Solution

Question

Finance

image

BCD, designs, manufactures, and markets medical devices. It reported earnings per share of $0.56 in 2013, on which it paid no dividends. It had revenues per share in 2013 of $2.91. It had capital expenditures of $0.13 per share in 2013 and depreciation in the same year of $0.08 per share. The working capital was 60% of revenues in 2013 and will remain at that level from 2014 to 2018, while earnings and revenues are expected to grow 17% a year. The earnings growth rate is expected to decline linearly over the following five years to a rate of 5% in 2003. During the high growth and transition periods, capital spending and depreciation are expected to grow at the same rate as earnings, but they are expected to offset each other when the firm reaches steady state. Working capital is expected to drop from 60% of revenues during the 2014-2018 period to 30% of revenues after 2023. The firm has no debt currently, but it plans to finance 10% of its net capital investment and working capital requirements with debt. The stock is expected to have a beta of 1.45 for the high-growth period (2014-2018), and it is expected to decline to 1.10 by the time the firm goes into steady state (in 2023). The treasury bond rate is 7%. a. Estimate the value per share, using the FCFE model. b. Estimate the value per share, assuming that working capital stays at 60% of revenues forever. c. Estimate the value per share, assuming that the beta remains unchanged at 1.45 forever. BCD, designs, manufactures, and markets medical devices. It reported earnings per share of $0.56 in 2013, on which it paid no dividends. It had revenues per share in 2013 of $2.91. It had capital expenditures of $0.13 per share in 2013 and depreciation in the same year of $0.08 per share. The working capital was 60% of revenues in 2013 and will remain at that level from 2014 to 2018, while earnings and revenues are expected to grow 17% a year. The earnings growth rate is expected to decline linearly over the following five years to a rate of 5% in 2003. During the high growth and transition periods, capital spending and depreciation are expected to grow at the same rate as earnings, but they are expected to offset each other when the firm reaches steady state. Working capital is expected to drop from 60% of revenues during the 2014-2018 period to 30% of revenues after 2023. The firm has no debt currently, but it plans to finance 10% of its net capital investment and working capital requirements with debt. The stock is expected to have a beta of 1.45 for the high-growth period (2014-2018), and it is expected to decline to 1.10 by the time the firm goes into steady state (in 2023). The treasury bond rate is 7%. a. Estimate the value per share, using the FCFE model. b. Estimate the value per share, assuming that working capital stays at 60% of revenues forever. c. Estimate the value per share, assuming that the beta remains unchanged at 1.45 forever

Answer & Explanation Solved by verified expert
Get Answers to Unlimited Questions

Join us to gain access to millions of questions and expert answers. Enjoy exclusive benefits tailored just for you!

Membership Benefits:
  • Unlimited Question Access with detailed Answers
  • Zin AI - 3 Million Words
  • 10 Dall-E 3 Images
  • 20 Plot Generations
  • Conversation with Dialogue Memory
  • No Ads, Ever!
  • Access to Our Best AI Platform: Flex AI - Your personal assistant for all your inquiries!
Become a Member

Other questions asked by students